0 CHECKOUT

PRODUCT FILTERS

REGION

19
1
1
1

COUNTRY

1

CATEGORIES

  • 12
  • 10
  • 8
  • 7
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

4
12
15
65

PUBLISHED

1
10
43
65

PRODUCT TYPE

53
9
3

Search for: "MultiCell Technologies Inc.-Therapeutic Competitors"

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

Published:  April 2015
Price:  From

Stem Cell Research Products - Opportunities, Tools, & Technologies

This global strategic report will help you understand unique product opportunities by stem cell type, derive more revenue from products sold to stem cell scientists, and identify new product development...

Published:  February 2016
Price:  From

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  April 2015
Price:  From

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015’, provides an overview of the Hematopoietic Stem...

Published:  May 2015
Price:  From

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  June 2015
Price:  From

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

Published:  November 2014
Price:  From

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

Published:  March 2015
Price:  From

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015 Summary The report ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015’, provides an overview of the Peripheral...

Published:  September 2015
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015 Summary The report ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015’, provides an overview...

Published:  August 2015
Price:  From

Spinal Cord Injury - Pipeline Review, H2 2015

Spinal Cord Injury - Pipeline Review, H2 2015 Summary The report ‘Spinal cord Injury - Pipeline Review, H2 2015’, provides an overview of the Spinal cord Injury’s therapeutic pipeline. This report...

Published:  August 2015
Price:  From

Spinal Cord Injury - Pipeline Review, H1 2015

Spinal Cord Injury - Pipeline Review, H1 2015 Summary This, ‘Spinal Cord Injury - Pipeline Review, H1 2015’, provides an overview of the Spinal Cord Injury’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Myocardial Infarction - Pipeline Review, H1 2015

Myocardial Infarction - Pipeline Review, H1 2015 Summary: This, ‘Myocardial Infarction - Pipeline Review, H1 2015’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This...

Published:  March 2015
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  January 2015
Price:  From

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review,...

Published:  June 2015
Price:  From

Hepatocellular Carcinoma - Pipeline Review, H1 2015

Hepatocellular Carcinoma - Pipeline Review, H1 2015 Summary the, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Subcutaneous Biologics Market, 2015 - 2025

Amongst various efforts to ensure efficient drug delivery, subcutaneous administration has emerged as one of the most promising approaches to deliver viscous biologic drugs in a patient friendly format....

Published:  January 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

Published:  March 2015
Price:  From

Myocardial Infarction - Pipeline Review, H2 2015

Myocardial Infarction - Pipeline Review, H2 2015 Summary The report ‘Myocardial Infarction - Pipeline Review, H2 2015’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This...

Published:  September 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015 Summary The report ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus Host Disease...

Published:  September 2015
Price:  From
Loading Indicator

Our Clients

  • Innocent Drinks Ltd.
  • Groupe Danone
  • Cisco Systems, Inc.
  • The World Bank Group
  • Swarovski AG
  • Owens Corning Corporation
  • Swiss Reinsurance Company Ltd.